参考文献
-
1) Hepatoprotective effects of polysaccharide from Morchella esculenta are associated with activation of the AMPK/Sirt1 signaling pathway in mice with NAFLD.
-
2) Mechanisms underlying the effects of the conditional knockdown of hepatic PCSK9 in attenuating lipopolysaccharide-induced acute liver inflammation.
-
3) 17β-Trenbolone increases circulating myeloid-derived MMP8 in CSDS-induced mice and drives depressive tendencies to social threat.
-
4) lncRNA ENST000000454471 promotes lung adenocarcinoma progression and tumor immune escape: Protein structure and biological functions of histone deacetylase 8.
-
5) Acute hyperglycemia impedes spinal cord injury recovery via triggering excessive ferroptosis of endothelial cells.
-
6) A novel nuclear receptor NR1D1 suppresses HSD17B12 transcription to regulate granulosa cell apoptosis and autophagy via the AMPK pathway in sheep.
-
7) Lycium barbarum polysaccharide mitigates high-fat-diet-induced skeletal muscle atrophy by promoting AMPK/PINK1/Parkin-mediated mitophagy.
-
8) Polyguluronate sulfate has potential to mitigate hyperlipidemia by inhibiting the PCSK9-mediated degradation of LDLR.
-
9) High-resolution LC-MS/MS combined with TMT quantitative proteomic analysis reveals regulatory mechanism of sperm capacitation by heparin, Ca2+ and BSA.
-
10) Perfluorooctane sulfonate induced ferritinophagy via detyrosinated alpha tubulin-TRIM21-HERC2-regulated NCOA4 degradation in hepatocytes.
-
11) GSH-responsive targeted copper-based nanoparticle improve ovarian cancer treatment via induction of apoptosis-ferroptosis-cuproptosis.
-
12) GPNMB and ATP6V1A interact to mediate microglia phagocytosis of multiple types of pathological particles.
-
13) Human dental follicle stem cell-derived exosomes reduce root resorption by inhibiting periodontal ligament cell pyroptosis.
-
14) Metabolite-dependent m6A methylation driven by mechanotransduction-metabolism-epitranscriptomics axis promotes bone development and regeneration.
-
15) BCG-trained macrophages couple LDLR upregulation to type I IFN responses and antiviral immunity.
製品: 1Year: 2025ジャーナル: CELL REPImpactFactor: 7.500DOI: 10.1016/j.celrep.2025.115493.epub2025apr1.